Medicenna Therapeutics Corp. begins trading today on OTCQX under the symbol “MDNAF ... MDNAF), a clinical-stage immunotherapy company foc TORONTO and HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE ...
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is ...
Grindr Inc. ("Grindr" or the "Company"), the Global Gayborhood in Your PocketTM, today announced the "Redemption Fair Market Value" to be used in connection with the previously announced redemption of ...
BofA has initiated coverage of Candel Therapeutics (CADL) with a buy rating, citing the potential of its immunotherapy drug candidates CAN-2409 and CAN-3110. Read more here.
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced ...
Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...
Tevogen Bio ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN), is a clinical-stage specialty immunotherapy biotech company. As the biopharma industry ...
Detailed price information for Briacell Therapeutics Corp (BCT-T) from The Globe and Mail including charting and trades.
Immunotherapy is the treatment of disease by inducing, enhancing or suppressing an immune response. Activation immunotherapies induce or amplify an immune response and are used in vaccines and as ...
Venture Symbol: SRR All Issues: Yes Resumption (ET): 9:30 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company.
The bill would make it harder for insurance companies to deny coverage and require them to provide the criteria used to deny coverage based on medical necessity. Other news includes: suicide trends in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results